期刊文献+

非手术治疗中晚期肝癌生存七年一例 被引量:1

下载PDF
导出
摘要 1病例介绍 患者男,54岁,于2002年8月12日上午首次入我院普外科。患者自述自2002年上半年因上腹疼痛,逐渐消瘦,经当地县医院超声、CT、AFP及血、尿糖检测诊断为肝转移癌,慢性胆囊炎及胰岛素依赖型糖尿病。随后为进一步求治曾先后去多家医院,均诊断为原发性肝癌中晚期。
机构地区 中国人民解放军
出处 《中国现代普通外科进展》 CAS 2009年第9期827-828,共2页 Chinese Journal of Current Advances in General Surgery
  • 相关文献

参考文献6

  • 1Di Bisceqlie AM, Rustgi vk, Hoofnaqle JH, et al. NIH conference: Hepatocellular carcinoma[J].Ann Intern Med, 1988,108{3) :390-401.
  • 2韩大正,李瑞玲,王运杰,刘春霞.中、晚期肝癌瘤体内注射化疗药物的双介入治疗[J].中国乡村医药,2003,10(7):19-20. 被引量:2
  • 3黄俊星,吉学源.肝动脉栓塞化疗与干扰素治疗54例中晚期肝癌的疗效观察[J].新医学,1993,24(2):72-73. 被引量:7
  • 4Polyzos A, Tsavaris N, Vafiadis L, et al. Phase II study of gemcitabine plus 5-Flu orouracil biologically modulated by folinic acid plus long-actiy formulation of octreotide (LAR) in patients with edvanced oancereatic cancer[J].J BUON. 2005.10(3 ):357-364.
  • 5Sun He, Tang ZY, Wang L, et al. postoperative Intenferon alpha treatment Postponed recurrence and inproved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma;a randomized clinical trial [J].J Cancer Res Clin Oncol, 2006,132(7):458-465.
  • 6Mazzaferro V, Romito R, schiavo M, et al. Prevention of hepatocellular carcinoma recurrence with alpha-interfeion after live resection in HCV cirrhosis[J]. Hepatologs, 2006,44(6):1543-1554.

共引文献7

同被引文献12

  • 1孔丽,姚树坤,刘金星,王娜.原发性肝癌患者细胞免疫功能变化及其与转归的关系[J].中华肝脏病杂志,2005,13(3):194-197. 被引量:61
  • 2Sugimori K,Nozawa A,Morimoto M,et al.Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge;results in a pig model[J].J Vasc Interv Radiol,2005,16(6):849-856.
  • 3Attallah AM,Tabll AA,El-Sadany M,et al.Dysregulation of blood lymphocyte subsets and natural killer cells in schistosoml liver cirrhosis and hepatocellular carcinoma[J].Clin Exp Med,2003,3(3):181-185.
  • 4Gollob JA,Wilhelm S,Carter C,et al.Role of Raf kinase in cancer:therapeutic potential of rargeting the Raf/MEK/ERK signal transduction pathway[J].Semin Oncol,2006,33(4):392-406.
  • 5Liu L,Cao Y,Chen C,et al.Sorafenib blocks the RAF/MEK/ERK pathway,inhibits tumor angiogenesis,and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5[J].Cancer Res,2006,66(24):11851-11858.
  • 6Polyzos A,Tsavaris N,Vafiadis L,et al.Phase Ⅱ study of gemcitabine plus 5-Fluorouracil biologically modulated by folinic acid plus long-actiy formulation of octreode (LAR) in patients with advanced pancereatic cancer[J].J BUON,2005,10(3):357-364.
  • 7Sun HC,Tang ZY,Wang L,et al.Postoperative interferon alpha treatment postponed recurrence and improved overall surrival in patients after curative resection of HBV-related hepatocellular carcinoma:a randomized clinical trial[J].J Cancer Res Clin Oncol,2006,132(7):458-465.
  • 8Mazzaferro V,Romito R,Schiavo M,et al.Prevention of hepatocellular carcinoma recurrence with alpha-interferon after live resection in HCV cirrhosis[J].Hepatology,2006,44(6):1543 -1554.
  • 9朱芳来,凌安生.经动脉灌注化疗栓塞联合经皮无水乙醇注射治疗原发性肝癌临床研究[J].介入放射学杂志,2008,17(4):286-289. 被引量:17
  • 10钟立清,徐寅聪,陆龙辉,孟凡龙.TACE、PEI双介入间隔疗法治疗晚期原发性肝细胞癌临床观察[J].白求恩军医学院学报,2009,7(2):69-71. 被引量:3

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部